SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : InterMune (nasdaq)ITMN -- Ignore unavailable to you. Want to Upgrade?


To: IRWIN JAMES FRANKEL who wrote (59)12/3/2000 1:26:18 PM
From: tuck  Respond to of 508
 
Just in case any of you wizards trade options, this from the Pacific Exchange:

"Intermune Pharmaceuticals, Inc. options will trade on the January expiration cycle. Position and exercise limits have been set at 13,500 contracts. IQY options have been allocated to lead market maker Ali Saadat of LETCO LMM LLC."

Cheers, Tuck